Literature DB >> 15225827

The effects of calcitriol on falls and fractures and physical performance tests.

J C Gallagher1.   

Abstract

There is an increase in the incidence of falls with aging and about 10% of falls lead to fractures. Nearly all hip fractures are due to falls and hip fractures are the most severe of the osteoporotic fractures because they lead to a 20% mortality rate and a loss of independent living in 50% of cases. Although there are multiple factors associated with falls, our interest is the role that vitamin D metabolism plays in the pathogenesis of falls. Recent clinical trials show that both vitamin D and the metabolite calcitriol reduce the number of falls by 30-40% in elderly subjects. This should also reduce the number of fractures. In European studies, the decrease in falls could be attributed to an improvement in the muscle weakness that often accompanies vitamin D deficiency. However, in the studies using calcitriol there was no vitamin D deficiency, so the mechanism of its efficacy is less clear. It could be due to increased muscle strength, an improvement in the neurological control of balance or both. Understanding these mechanisms would allow us to search for analogs of vitamin D that act more selectively on muscle and on the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15225827     DOI: 10.1016/j.jsbmb.2004.03.059

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  29 in total

1.  Calcifediol versus vitamin D3 effects on gait speed and trunk sway in young postmenopausal women: a double-blind randomized controlled trial.

Authors:  O Meyer; B Dawson-Hughes; E Sidelnikov; A Egli; D Grob; H B Staehelin; G Theiler; R W Kressig; H P Simmen; R Theiler; H A Bischoff-Ferrari
Journal:  Osteoporos Int       Date:  2014-11-05       Impact factor: 4.507

Review 2.  Frailty and hormones.

Authors:  John E Morley; Moon Jong Kim; Matthew T Haren
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

Review 3.  The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

Authors:  Luisella Cianferotti; Claudio Cricelli; John A Kanis; Ranuccio Nuti; Jean-Y Reginster; Johann D Ringe; Rene Rizzoli; Maria Luisa Brandi
Journal:  Endocrine       Date:  2015-05-01       Impact factor: 3.633

Review 4.  "Nutraceuticals" in relation to human skeletal muscle and exercise.

Authors:  Colleen S Deane; Daniel J Wilkinson; Bethan E Phillips; Kenneth Smith; Timothy Etheridge; Philip J Atherton
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-01-31       Impact factor: 4.310

5.  Vitamin D deficiency and muscle strength: are they related?

Authors:  J Christopher Gallagher
Journal:  J Clin Endocrinol Metab       Date:  2012-12       Impact factor: 5.958

6.  Is the 25-Hydroxy-Vitamin D Serum Concentration a Good Marker of Frailty?

Authors:  T Krams; M Cesari; S Guyonnet; G Abellan Van Kan; C Cantet; B Vellas; Y Rolland
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

7.  Impact of 3-Monthly Vitamin D Supplementation Plus Exercise on Survival after Surgery for Osteoporotic Hip Fracture in Adult Patients over 50 Years: A Pragmatic Randomized, Partially Blinded, Controlled Trial.

Authors:  A Laiz; J Malouf; A Marin; V Longobardi; J de Caso; J Farrerons; J Casademont
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

8.  Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial).

Authors:  J D Ringe; P Farahmand; E Schacht; A Rozehnal
Journal:  Rheumatol Int       Date:  2007-03       Impact factor: 2.631

9.  Independent from muscle power and balance performance, a creatinine clearance below 65 ml/min is a significant and independent risk factor for falls and fall-related fractures in elderly men and women diagnosed with osteoporosis.

Authors:  L Dukas; E Schacht; M Runge
Journal:  Osteoporos Int       Date:  2009-09-22       Impact factor: 4.507

Review 10.  The efficacy of calcitriol therapy in the management of bone loss and fractures: a qualitative review.

Authors:  L J Peppone; S Hebl; J Q Purnell; M E Reid; R N Rosier; K M Mustian; O G Palesh; A J Huston; M N Ling; G R Morrow
Journal:  Osteoporos Int       Date:  2009-12-04       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.